<?xml version="1.0" encoding="UTF-8"?>
<p>It has been reported that the methanolic extract of 
 <italic>Terminalia coriacea</italic> (Roxb.) Wight &amp; Arn. (
 <italic>Terminalia coriacea</italic> Spreng.) leaves reduce the paw edema and the weights of granulomatous tissue in both acute and chronic 
 <italic>in vivo</italic> inflammatory models (
 <xref rid="B77" ref-type="bibr">Khan et al., 2018</xref>). 
 <italic>Terminalia cunninghamii</italic> C.A.Gardner, is a native nut traditionally used by Australian Indigenous peoples for oxidant-related issues (
 <xref rid="B205" ref-type="bibr">Zhong et al., 2018</xref>). The fruit and leaf extracts of 
 <italic>Terminalia ferdinandiana</italic> Exell, an endemic Australian plant, have been found to possess strong antibacterial activity against various bacterial pathogens (
 <xref rid="B39" ref-type="bibr">Cheesman et al., 2019</xref>). The leaf extract of 
 <italic>T. ferdinandiana</italic> Exell has a potent growth inhibition effect on plantar malodor-producing bacteria (
 <xref rid="B113" ref-type="bibr">Mcmanus et al., 2017</xref>). It has also been reported that extracts from 
 <italic>T. ferdinandiana</italic> Exell down-regulate the growth of 
 <italic>Shewanella</italic> sp., which are essential causes of fish spoilage (
 <xref rid="B199" ref-type="bibr">Wright et al., 2019</xref>). 
 <italic>Terminalia laxiflora</italic> Engl. contains a wide variety of antimycobacterial compounds, including ellagitannins, ellagic acid derivatives, triterpenes, fatty acids, and fatty alcohols (
 <xref rid="B175" ref-type="bibr">Salih et al., 2018</xref>). Evidence indicates that the fungal extract from 
 <italic>T. laxiflora</italic> Engl. affects the NF-κB signaling pathway in K562 myelogenous leukemia cell line (
 <xref rid="B188" ref-type="bibr">Tawfike et al., 2018</xref>). In Mali, 
 <italic>Terminalia macroptera</italic> Guill. &amp; Perr. is one of the most widely used plants for malaria in traditional medicine (
 <xref rid="B160" ref-type="bibr">Pham et al., 2014</xref>). The first 
 <italic>in vitro</italic>
 <italic>T. macroptera</italic> Guill. &amp; Perr. study in 1996 found that the roots and leaves of 
 <italic>T. macroptera</italic> Guill. &amp; Perr. hold antibacterial activity (
 <xref rid="B182" ref-type="bibr">Silva et al., 1996</xref>). The safety of the use of 
 <italic>T. macroptera</italic> Guill. &amp; Perr. in malaria was further confirmed in the following studies using an 
 <italic>in vivo</italic> Albino Swiss mice model (
 <xref rid="B66" ref-type="bibr">Haidara et al., 2018</xref>). 
 <italic>Terminalia sericea</italic> Burch. ex DC. is traditionally used in the treatment of stomach ailments, infections, hypertension, and diabetes mellitus (
 <xref rid="B32" ref-type="bibr">Busisani et al., 2018</xref>). Recent studies in medical sciences have revealed that the potential of 
 <italic>T. sericea</italic> Burch. ex DC. includes: antiviral, antibacterial, antitumor, antiinflammatory, antioxidant, and wound healing activities (
 <xref rid="B56" ref-type="bibr">Fan et al., 2015</xref>).
</p>
